|
T-cell activation assay
|
BAO_0010253 |
|
|
Marfan syndrome
|
DOID_14323 |
|
|
epithelial-myoepithelial carcinoma
|
DOID_5309 |
|
|
protein expression assay
|
BAO_0010252 |
|
|
T-cell engraftment
|
BAO_0010255 |
|
|
mixed malaria
|
DOID_14325 |
|
|
syngeneic tumor model
|
BAO_0010254 |
|
|
signaling pathway assay
|
BAO_0010251 |
|
|
cell binding assay
|
BAO_0010250 |
|
|
protein kinase G agonist
|
CHEBI_64105 |
|
|
Dahl salt-sensitive rat model
|
BAO_0010257 |
|
|
in vivo PK/PD assay
|
BAO_0010256 |
|
|
generalized anxiety disorder
|
DOID_14320 |
|
|
target engagement assay
|
BAO_0010259 |
|
|
concentration response assay
|
BAO_0010258 |
|
|
EC 4.6.1.1 (adenylate cyclase) inhibitor
|
CHEBI_90365 |
|
|
AMPA receptor agonist
|
CHEBI_64102 |
|
|
concentration unit
|
UO_0000051 |
|
|
ovarian clear cell adenocarcinoma
|
DOID_5304 |
|
|
rotational frequency unit
|
UO_0000058 |
|
